Technology Intervention for Diabetes Engagement & Self-Care (TIDES)

Geisinger Health

Status: Completed

Conditions: Diabetes Mellitus Type 2

Treatments: Other: Usual Care; Behavioral: Educational Intervention

Study type: Interventional

Funder types: Other

Identifiers

NCT01440530

2010-0173

Details and patient eligibility

About

The purpose of this 3 site, 24-week, Comparative Effectiveness Randomized Clinical Trial in Primary Care is to compare usual care to an online, multi-media, digital intervention for Persons with Type 2 Diabetes to Improve Engagement, Knowledge, and Self-Care.

Full description

Objective: Technology shows promise to enhance standard care of diabetes with cost-effective, online lifestyle interventions. Compared to Primary Care (PC) Diabetes System of Care (control), the investigators hypothesized Technology Intervention for Diabetes Engagement & Self-Care (TIDES) would significantly improve diabetes knowledge and self-care.

Methods: Following Institutional Review Board (IRB) approval, physician letters were sent to patients with type 2 diabetes, age >18 years with HgA1c >8% identified via Electronic Health Record (EHR) of an integrated US health system to invite participation in a 3-site, 24-week diabetes study. Of the 270 with >1 week email/web use invited to the shared medical visit (SMV) orientation, 166 subjects provided written informed consent. Diabetes knowledge and self-care assessments, vital signs, HgA1c, fasting glucose and lipids were collected at baseline, 3 and 6 months. Following randomization to TIDES (N=117) or usual care (N=49), TIDES group was oriented to the multimedia online intervention including a dosed sequence of learning via email, video, slide shows, food solutions, expert questions and answers,and quizzes.

Enrollment: 170 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diabetes Mellitus Type 2
• Geisinger Primary Care Provider
• Access to a computer

Exclusion criteria

• Severe medical problems that limits travel to primary care
• Diabetes Type 1
• Cognitive Impairment
• Taking anti-psychotic meds

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

170 participants in 2 patient groups

Educational Intervention

Experimental group

Treatment:

Behavioral: Educational Intervention

Control Group (usual care)

Active Comparator group

Treatment:

Other: Usual Care